![John L. Mee](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
John L. Mee active positions
Companies | Position | Start | End |
---|---|---|---|
Cognigenics, Inc.
![]() Cognigenics, Inc. Miscellaneous Commercial ServicesCommercial Services Cognigenics, Inc. is a company founded in 2019 that specializes in genetic neuroengineering using patent-pending CRISPR technology to target and modulate neural circuits responsible for mental health disorders such as anxiety, depression, ADHD, and cognitive impairment. The company is based in Eagle, ID. Cognigenics is revolutionizing the treatment of mental health conditions through their innovative technology. The company was founded by John L. Mee, Dean Radin, and Barry J. Linder, with John L. Mee serving as CEO since incorporation. | President | 13/01/2024 | - |
Founder | - | - | |
Chief Executive Officer | - | 13/01/2024 |
Career history of John L. Mee
Statistics
International
United States | 2 |
Operational
Chief Executive Officer | 1 |
Founder | 1 |
President | 1 |
Sectoral
Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 1 |
---|---|
Cognigenics, Inc.
![]() Cognigenics, Inc. Miscellaneous Commercial ServicesCommercial Services Cognigenics, Inc. is a company founded in 2019 that specializes in genetic neuroengineering using patent-pending CRISPR technology to target and modulate neural circuits responsible for mental health disorders such as anxiety, depression, ADHD, and cognitive impairment. The company is based in Eagle, ID. Cognigenics is revolutionizing the treatment of mental health conditions through their innovative technology. The company was founded by John L. Mee, Dean Radin, and Barry J. Linder, with John L. Mee serving as CEO since incorporation. | Commercial Services |
- Stock Market
- Insiders
- John L. Mee
- Experience